Disc Medicine Stock (NASDAQ:IRON)
Previous Close
$70.28
52W Range
$30.82 - $72.68
50D Avg
$61.41
200D Avg
$54.87
Market Cap
$2.46B
Avg Vol (3M)
$374.83K
Beta
2.50
Div Yield
-
IRON Company Profile
Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.